VAERS reports by lot

Moderna COVID-19 lot MODERNACOVID-1: VAERS reports

62 VAERS reports list lot MODERNACOVID-1 as a Moderna COVID-19 vaccine, received between 2020-12-30 and 2024-12-10. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
62
Reports
2%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7425%
Injection-site / Local reaction4917%
Neurological4315%
Musculoskeletal3512%
Gastrointestinal248%
Dermatological (non-injection-site)238%
Cardiac / Cardiovascular186%
Respiratory114%
Allergic / Anaphylactic83%
Psychiatric / Neuropsychiatric62%
Reproductive / Menstrual10%

Where reports came from

U.S. state of the reporter, where given (top 12).

New York7
Minnesota5
Florida4
Colorado4
New Jersey3
Virginia3
California3
Washington3
Pennsylvania2
Maryland2
Georgia2
Connecticut2

Reports by month received

2020-122
2021-0115
2021-0214
2021-0322
2021-046
2021-051
2022-031
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.